Actively Recruiting
Efficacy of Visually Guided Transversus Abdominis Plane (TAP) Block in Recovery After Laparoscopic Inguinal Hernia Repair (TAPP)
Led by University of Warmia and Mazury in Olsztyn · Updated on 2026-03-17
100
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how well the Transversus Abdominis Plane (TAP) block performed under direct laparoscopic vision reduces pain and improves recovery after laparoscopic inguinal hernia repair using the TAPP (Transabdominal Preperitoneal) technique. This prospective, randomized clinical study will include 100 adults undergoing elective laparoscopic TAPP hernia repair, aiming to find a simple and safe pain control method during minimally invasive surgery. Participants will be randomly assigned to two groups. The study group will receive a bilateral TAP block under direct laparoscopic vision with 20 ml of 0.25% bupivacaine injected on each side after creating pneumoperitoneum. The control group will have the same laparoscopic TAPP repair without the TAP block. All patients will get standard general anesthesia and postoperative pain management, including scheduled analgesics and rescue medications if needed. During the study, pain intensity will be measured using the Visual Analogue Scale (VAS) at 0, 6, and 12 hours after surgery at various surgical sites. Researchers will also track time to first mobilization, total analgesic use, and any postoperative complications such as hematoma or transient muscle weakness. The main outcome is pain intensity at 6 hours post-surgery, with other recovery and safety measures recorded. The study will last until March 2027.
CONDITIONS
Brief Title
Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-80 years
- Scheduled for elective laparoscopic inguinal hernia repair using the TAPP technique
- ASA physical status I-III
- Ability to provide written informed consent
- No contraindications to regional anesthesia or local anesthetic administration
You will not qualify if you...
- Recurrent or strangulated inguinal hernia
- Emergency surgery
- Chronic pain syndromes or preoperative opioid use
- Known allergy or hypersensitivity to local anesthetics (bupivacaine or similar)
- Severe hepatic or renal impairment
- Psychiatric disorders or inability to provide informed consent
- Conversion to open surgery during the procedure
- Technical difficulties preventing TAP block administration
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo laparoscopic inguinal hernia repair using the TAPP technique. Those in the TAP Block Group receive a bilateral Transversus Abdominis Plane block under direct laparoscopic vision during surgery to provide regional anesthesia. All participants receive standardized general anesthesia and postoperative pain management.
1 surgical visit (in-person)
Duration - Up to 24 hours after surgery
Participants are monitored for postoperative pain intensity at 0, 6, and 12 hours, time to first mobilization, analgesic use, recovery evaluated by Post Anesthesia Discharge Scoring System, and possible adverse events within 24 hours after surgery.
Assessments at 0, 6, and 12 hours after surgery; up to 3 visits (in-person)
Trial Site Locations
Total: 1 location
1
University Clinical Hospital in Olsztyn, Department of General and Oncological Surgery
Olsztyn, Warmisko-mazurskie, Poland, 10-041
Actively Recruiting
Research Team
Ł
Łukasz Dyśko, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here